US clears first 'living drug' for childhood leukaemia

US clears first 'living drug' for childhood leukaemia

US officials have approved the first treatment that genetically engineers patients' own blood cells to seek and destroy a childhood leukaemia.

The CAR-T cell treatment developed by Novartis and the University of Pennsylvania is the first type of gene therapy to hit the US market - and one in a powerful but expensive wave of custom-made "living drugs" being tested against blood cancers and some other tumours.

The Food and Drug Administration called the approval historic.

"This is a brand new way of treating cancer," said Dr Stephan Grupp of Children's Hospital of Philadelphia, who treated the first child with CAR-T cell therapy - a girl who had been close to death, but now is cancer-free for five years and counting.

"That's enormously exciting."

CAR-T treatment uses gene therapy techniques not to fix disease-causing genes, but to "turbo-charge" T cells, immune system "soldiers" that cancer can often evade.

Researchers filter the cells from a patient's blood, reprogramme them with a "chimeric antigen receptor" that targets cancer, and grow hundreds of millions of copies.

Returned to the patient, the cells can continue multiplying to fight disease for months or years.

Novartis did not immediately disclose the therapy's price, but it is expected to cost hundreds of thousands of dollars. It is made from scratch for every patient.

"We're entering a new frontier in medical innovation with the ability to reprogramme a patient's own cells to attack a deadly cancer," said FDA commissioner Scott Gottlieb.

This first use of CAR-T therapy is aimed at patients desperately ill with acute lymphoblastic leukaemia, which strikes more than 3,000 children and young adults in the US each year.

While most survive, about 15% relapse despite the current best treatments, and their prognosis is bleak.

In a key study of 63 advanced patients, 83% went into remission, although it is not clear how long the benefit lasts: Some patients did relapse months later.

The others still are being tracked to see how they fare long-term.

AP

More on this topic

Almost 600 patients waiting for beds in hospitals across the countryAlmost 600 patients waiting for beds in hospitals across the country

Harris announces measures to ease pressures on emergency departmentsHarris announces measures to ease pressures on emergency departments

597 patients waiting for beds countrywide597 patients waiting for beds countrywide

New research study to explore long-term effects of repeated concussionNew research study to explore long-term effects of repeated concussion

More in this Section

BFFs: Close friends help macaques surviveBFFs: Close friends help macaques survive

Food labels showing exercise needed to burn calories ‘could help tackle obesity’Food labels showing exercise needed to burn calories ‘could help tackle obesity’

Poll prediction shows Tory hit but Boris Johnson still on course for majorityPoll prediction shows Tory hit but Boris Johnson still on course for majority

Bird flu found on English chicken farmBird flu found on English chicken farm


Lifestyle

Ray Liotta never planned to be an actor. He only signed up for drama classes in college in a bid to dodge the more academic subjects, and didn’t make his first film until he was 30.Both sides now: Ray Liotta on his 40 year career

I am Jesus Christ! No, don’t worry, this writer’s ego isn’t quite that big. We won’t be turning water into wine. Rather, ‘I Am Jesus Christ’ is the name of a new game just announced on Steam.GameTech: The new video game 'I am Jesus Christ'

Johnny ‘Fang’ Murphy, frontman with Cork group The Stargazers, tells Ellie O’Byrne about the cultural milestones on his musical journey.Getting into the swing of things: Johnny 'Fang' Murphy on his musical journey

Clean skincare is cleaning up, but does it even mean anything in particular?The Skin Nerd: When clean does not always mean better

More From The Irish Examiner